Paper41545871
Activation of the pituitary adenylate cyclase-activating polypeptide type I receptor promotes neuroblastoma proliferation and migration through distinct G protein pathways.
Jang S and 2 others. Cell Commun Signal, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Activation of the pituitary adenylate cyclase-activating polypeptide type I receptor promotes neuroblastoma proliferation and migration through distinct G protein pathways. Papers, record 41545871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of the pituitary adenylate cyclase-activating polypeptide type I receptor promotes neuroblastoma proliferation and migration through distinct G protein pathways.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroblastoma | Major topic |
| Cell Movement | Major topic |
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | Major topic |
| Signal Transduction | Major topic |
| GTP-Binding Proteins | Major topic |
| Cell Proliferation | |
| Humans | |
| Cell Line, Tumor | |
| Pituitary Adenylate Cyclase-Activating Polypeptide |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RS-2020-NR049538 | National Research Foundation of Korea | PubMed |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30088106 | PACAP38 and PAC1 receptor blockade: a new target for headache? | J Headache Pain | 2018 | https://conductscience.org/library/papers/30088106 | PubMed |
| 2 | 28966937 | Origin and mechanism of neuroblastoma. | Oncoscience | 2017 | https://conductscience.org/library/papers/28966937 | PubMed |
| 3 | 16226889 | Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. | Mol Cell Neurosci | 2006 | https://conductscience.org/library/papers/16226889 | PubMed |
| 4 | 11166697 | Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons. | Brain Res | 2001 | https://conductscience.org/library/papers/11166697 | PubMed |
| 5 | 29246327 | In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/29246327 | PubMed |
| 6 | 17651798 | The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1. | Cell Calcium | 2008 | https://conductscience.org/library/papers/17651798 | PubMed |
| 7 | 19109992 | VPAC and PAC receptors: From ligands to function. | Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19109992 | PubMed |
| 8 | 23517078 | VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23517078 | PubMed |
| 9 | 35897648 | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35897648 | PubMed |
| 10 | 2383262 | Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). | Biochem Biophys Res Commun | 1990 | https://conductscience.org/library/papers/2383262 | PubMed |
| 11 | 20879880 | Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20879880 | PubMed |
| 12 | 22529259 | Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22529259 | PubMed |
| 13 | 35053757 | The PACAP/PAC1 Receptor System and Feeding. | Brain Sci | 2021 | https://conductscience.org/library/papers/35053757 | PubMed |
| 14 | 31284862 | Targeting the PAC1 Receptor for Neurological and Metabolic Disorders. | Curr Top Med Chem | 2019 | https://conductscience.org/library/papers/31284862 | PubMed |
| 15 | 22389426 | Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. | J Pharmacol Exp Ther | 2012 | https://conductscience.org/library/papers/22389426 | PubMed |
| 16 | 35302493 | Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. | Elife | 2022 | https://conductscience.org/library/papers/35302493 | PubMed |
| 17 | 28692064 | Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis. | Nat Med | 2017 | https://conductscience.org/library/papers/28692064 | PubMed |
| 18 | 22532442 | Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. | FASEB J | 2012 | https://conductscience.org/library/papers/22532442 | PubMed |
| 19 | 29298813 | G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? | Mol Pharmacol | 2018 | https://conductscience.org/library/papers/29298813 | PubMed |
| 20 | 12880962 | Genetic and epigenetic alterations in neuroblastoma. | Cancer Lett | 2003 | https://conductscience.org/library/papers/12880962 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42862439 | Pituitary adenomas (PitNETs): molecular pathophysiology, targeted drug delivery strategies and clinical therapeutic outcomes. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42862439 | PubMed |
| 42346154 | PACAP and Maxadilan (PAC1 Agonist) Influence Plaque Progression, Migratory Ability, and Mitochondrial Morphology and Dynamics in Vascular Smooth Muscle Cells. | Cells | 2026 | https://conductscience.org/library/papers/42346154 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADCYAP1R1 | 117 | PubTator's text mining | https://conductscience.org/library/genes/117 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545871
GET https://conductscience.org/api/papers/v1/41545871/references?page=2